Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

Pharmacists handed guide to changes in drug driving rules

Guide from the Royal Pharmaceutical Society covers advice for patients and details drugs affected by new legislation.

Guide from the Royal Pharmaceutical Society (RPS) covers advice for patients and details drugs affected by new legislation

Source: CristinaMuraca / Shutterstock.com 

New legislation allows a defence if drugs are taken as instructed

A quick reference guide to help pharmacists advise patients about new drug driving rules has been published by the Royal Pharmaceutical Society (RPS).

Legislation that makes it an offence to drive with high blood levels of certain drugs will come into force on 2 March 2015 in England and Wales.

Existing legislation prohibits driving while impaired due to legal or illegal drugs, meaning patients can be prosecuted for driving when taking certain medicines as prescribed if their driving is impaired.

From March, there will be an additional offence of driving under the influence of specified levels of 16 drugs, eight of which are for medicinal purposes. These specified limits allow for normal recommended doses.

However, the new law also provides a statutory ‘medical defence’ for patients who take their medicines as instructed by a health professional, such as a pharmacist, or product information – providing this does not impair their driving.

The RPS resource explains the changes to the law, lists the 16 drugs specified and provides a flowchart to summarise how the new drug driving rules work alongside the existing law.

It explains that pharmacists’ advice on how to take certain drugs can be used as the basis for the patient’s ‘medical defence’, and sets out advice for patients about how their treatment could affect their ability to drive.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20067853

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.